BioCentury - Boehringer launches open-access preclinical platform
lkfitz's bookmarks 2017-11-22
Summary:
"Boehringer Ingelheim GmbH (Ingelheim, Germany) launched a platform to provide researchers worldwide with open and free access to select preclinical-stage molecules."